- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 471/18 - Bridged systems
Patent holdings for IPC class C07D 471/18
Total number of patents in this class: 545
10-year publication summary
|
43
|
37
|
26
|
48
|
31
|
44
|
45
|
43
|
49
|
28
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Bristol-myers Squibb Company | 4742 |
37 |
| Janssen Pharmaceutica N.V. | 3168 |
35 |
| Gilead Sciences, Inc. | 2222 |
33 |
| Pathios Therapeutics Limited | 31 |
16 |
| Sanofi | 4301 |
15 |
| Rigel Pharmaceuticals, Inc. | 507 |
11 |
| Abbott Laboratories | 2254 |
10 |
| Purdue Pharma L.P. | 486 |
9 |
| Lumiphore, Inc. | 36 |
8 |
| Centre National de La Recherche Scientifique | 11023 |
7 |
| Guerbet | 204 |
7 |
| Novartis AG | 10262 |
6 |
| Genentech, Inc. | 4104 |
6 |
| Universite de Bretagne Occidentale | 106 |
6 |
| Achieve Life Sciences, Inc. | 45 |
6 |
| Shionogi & Co., Ltd. | 880 |
5 |
| The University of Bristol | 264 |
5 |
| Merck Sharp & Dohme LLC | 3734 |
5 |
| PH Health Limited | 141 |
5 |
| The Trustees of Columbia University in the City of New York | 3644 |
4 |
| Other owners | 309 |